Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Valvular disease associated with systemic illness

C A Roldan1

  • 1Echocardiography Laboratory, Veterans Affairs Medical Center, Albuquerque, New Mexico, USA.

Cardiology Clinics
|September 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Middle cerebral artery blood flows by combining TCD velocities and MRA diameters: in vitro and in vivo validations.

Ultrasound in medicine & biology·2014
Same author

Middle cerebral artery resistivity and pulsatility indices in systemic lupus erythematosus: evidence for hyperperfusion.

Lupus·2011
Same author

Premature aortic stiffness in systemic lupus erythematosus by transesophageal echocardiography.

Lupus·2010
Same author

Arterial distensibility in systemic lupus erythematosus.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2009
Same author

Diagnostic value of transesophageal echocardiography in Libman-Sacks endocarditis.

Minerva cardioangiologica·2009
Same author

Quantitative assessment of valve thickness in normal subjects by transesophageal echocardiography.

The American journal of cardiology·2001
Same journal

At the Edge of the Possible: A New Standard for Cardiovascular Critical Care.

Cardiology clinics·2026
Same journal

End-of-Life Care in the Cardiovascular Intensive Care Unit.

Cardiology clinics·2026
Same journal

Strategies to Reduce Failure to Rescue after Cardiac Surgery.

Cardiology clinics·2026
Same journal

Embracing Enhanced Recovery After Cardiac Surgery Program.

Cardiology clinics·2026
Same journal

Post-Heart Transplantation Intensive Care Unit Recovery: A Phase-Based Approach.

Cardiology clinics·2026
Same journal

A Practical Guide to Intensive Care Unit Management after Left Ventricular Assist Device Implantation.

Cardiology clinics·2026
See all related articles

Connective tissue diseases often cause heart valve problems, but clinical detection is low. Echocardiography is key for early recognition and management of these serious valvular complications.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Connective tissue diseases (CTDs) are immune-mediated inflammatory conditions affecting musculoskeletal and mucocutaneous systems.
  • Cardiovascular involvement, particularly of heart valves, pericardium, and myocardium, is common in CTDs.
  • Specific CTDs like Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and Aortitis Syndrome (AKS) have characteristic valvular abnormalities.

Purpose of the Study:

  • To highlight the high prevalence and significant morbidity/mortality of valvular disease in CTDs.
  • To address the discrepancy between high echocardiographic prevalence and low clinical detection rates.
  • To emphasize the importance of early recognition and management of CTD-associated valvular disease.

Main Methods:

Related Experiment Videos

  • Review of echocardiographic series in patients with CTDs.
  • Analysis of clinical data regarding valvular disease prevalence and characteristics.
  • Comparison of CTD-associated valvulopathies with other common valvular diseases.

    • Main Results:

    • Valvular disease is highly prevalent in CTDs, with significant associated morbidity and mortality.
    • Clinical detection rates are low due to lack of awareness and overshadowing by other symptoms.
    • Distinct echocardiographic findings can help differentiate CTD-related valve abnormalities.

    Conclusions:

    • Early recognition and management are crucial for improving outcomes in CTD-associated valvular disease.
    • Echocardiography, particularly transesophageal echocardiography (TEE), is vital for accurate diagnosis and characterization.
    • Further research is needed on pathogenesis, evolution, and therapeutic effects in these patients.